DZ Bank AG Reiterates Sell Rating for PROSIEBENSAT1 MED. (PBSFF)
PROSIEBENSAT1 MED. (OTCMKTS:PBSFF)‘s stock had its “sell” rating reiterated by stock analysts at DZ Bank AG in a research report issued on Wednesday.
Separately, Barclays PLC raised shares of PROSIEBENSAT1 MED. from an “equal weight” rating to an “overweight” rating in a research report on Wednesday, January 25th.
PROSIEBENSAT1 MED. (OTCMKTS:PBSFF) opened at 42.182 on Wednesday. PROSIEBENSAT1 MED. has a 12-month low of $33.70 and a 12-month high of $51.22. The stock has a market cap of $9.65 billion and a PE ratio of 21.732. The firm’s 50-day moving average price is $42.63 and its 200 day moving average price is $40.37.
Receive News & Ratings for PROSIEBENSAT1 MED. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PROSIEBENSAT1 MED. and related companies with Analyst Ratings Network's FREE daily email newsletter.